![Caroline Thielen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Caroline Thielen currently works at Exevir Bio BV, as Director, Dendrogenix SA, as Director, and Promethera Therapeutics SA, as Director.
Caroline Thielen active positions
| Companies | Position | Start |
|---|---|---|
Exevir Bio BV
 Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Director/Board Member | - |
Promethera Therapeutics SA
 Promethera Therapeutics SA Pharmaceuticals: OtherHealth Technology Provides cell therapies for treatment of liver diseases | Director/Board Member | - |
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
19
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Exevir Bio BV
Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Health Technology |
Promethera Therapeutics SA
Promethera Therapeutics SA Pharmaceuticals: OtherHealth Technology Provides cell therapies for treatment of liver diseases | Health Technology |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer | Health Technology |
- Stock Market
- Insiders
- Caroline Thielen
